Crothall Healthcare Technology Solutions, an ISO 13485:2016 medical device life-cycle management company, and Asimily, a leader in connected medical device inventory, cybersecurity, and operational management, have announced a strategic partnership.
“All of our clients will now have access to a world-class service portfolio that provides for the management and oversight of a hospital’s entire life-cycle of connected medical devices and clinical technologies,” says Asimily’s founder and CEO Shankar Somasundaram. “This management and oversight include safety, cybersecurity, asset and risk management, technical support, and financial stewardship.”
“For many healthcare systems, the rapid adoption of connected medical device technology expands the potential cyber-attack surface, and creates a significant cybersecurity gap, therefore making it difficult to scale device security,” Somasundaram says. “All of our clients will now have access to a world-class service portfolio that provides for the management and oversight of a hospital’s entire life-cycle of connected medical devices and clinical technologies.”
With the partnership in place, Crothall and their clients will have visibility into the client’s connected medical device profiles. Asimily’s machine learning will then assess risk, prioritize actions, and allow for the development of mitigation strategies to reduce security vulnerabilities.
“Our partnership will enhance Crothall’s medical device security offering with Asimily’s technical expertise in medical device security while Asimily will have the opportunity to access Crothall’s on-site expertise for identified vulnerabilities and risk mitigation,” says Jim Cheek, president of Crothall HTS.
This offering will further allow Crothall and their clients to manage a full spectrum of capabilities: asset utilization; FDA recall notification; device vendor tracking; and user defined policy alerts in the environment. Moreover, the partnership enhances the abilities of Crothall and its clients to manage devices from initial capital planning to end-of-life.